কিডনি উত্পাদিত প্রোটিজ যে ধর্মান্তরিত plasmin এবং তাই প্রারম্ভিক ফাইব্রিনোলাইসিস plasminogen

urokinase's Usage Examples:

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals.

The human urokinase protein.

The Urokinase receptor, also known as urokinase plasminogen activator surface receptor (uPAR) or CD87 (Cluster of Differentiation 87), is a protein encoded.

There are two main plasminogen activators: urokinase (uPA) and tissue plasminogen activator (tPA).

as the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), the activators of plasminogen and hence fibrinolysis (the physiological.

It is closely related to urokinase.

serpin superfamily, is a coagulation factor that inactivates tPA and urokinase.

disorder is characterized by large amounts of the fibrinolytic enzyme urokinase-type plasminogen activator (uPA) in platelets.

Tissue plasminogen activator (t-PA) and urokinase are the agents that convert plasminogen to the active plasmin, thus allowing.

suPAR, soluble urokinase-type plasminogen activator receptor (NCBI Accession no.

varying number of copies in some plasma proteins including prothrombin and urokinase-type plasminogen activator, which are serine proteases belonging to MEROPS.

Ly6 also known as lymphocyte antigen 6 or urokinase-type plasminogen activator receptor (uPAR) is family of proteins that share a common structure but.

Urised Urispas Uristat Urobak Urodine urofollitropin (INN) urokinase alfa (INN) urokinase (INN) Urologic Uromitexan Uroplus Urovist Uroxatral (Sanofi-Aventis).

The clinical therapy test with urokinase and defibrase for cerebral infarction in China is effective and relatively.

Urokinase plasminogen activator receptor (uPAR) is a cofactor for plasminogen activation by urokinase plasminogen activator.

enzyme-linked immunosorbent assay (ELISA) that measures the amount of soluble urokinase plasminogen activator receptor (suPAR) in blood.

kinase, suppresses the cell motility and NF-kappa B mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase.

receive a patent in molecular biology, for a new production method of urokinase.

The Somatomedin B domain interacts with the urokinase receptor, and this interaction has been implicated in cell migration and.

"RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer.

urokinase's Meaning':

protease produced in the kidney that converts plasminogen to plasmin and so initiates fibrinolysis